Evolution of autoantibody responses in individuals at risk of rheumatoid arthritis

被引:12
|
作者
Falkenburg, Willem J. J. [1 ,2 ]
van Schaardenburg, Dirkjan [1 ,3 ]
机构
[1] Amsterdam Rheumatol & Immunol Ctr, Reade, Doctor Jan Van Breemenstr 2, NL-1056 AB Amsterdam, Netherlands
[2] Sanquin Res, Dept Immunopathol, POB 9892, NL-1006 AN Amsterdam, Netherlands
[3] Acad Med Ctr, Amsterdam Rheumatol & Immunol Ctr, POB 22660, NL-1100 DD Amsterdam, Netherlands
来源
关键词
Arthralgia; Pre-clinical rheumatoid arthritis; Rheumatoid factors; Anti-citrullinated protein antibodies; Epitope spreading; Glycosylation; Autoantibody interactions; CITRULLINATED PROTEIN ANTIBODIES; COLLAGEN-INDUCED ARTHRITIS; CD5+ B-CELLS; CONSTANT-REGION; INTRAVENOUS IMMUNOGLOBULINS; SEROPOSITIVE ARTHRALGIA; CARBAMYLATED PROTEINS; MEDIATED INFLAMMATION; AUTOIMMUNE-DISEASES; PEPTIDE ANTIBODIES;
D O I
10.1016/j.berh.2017.07.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autoantibodies such as rheumatoid factors (RFs), anti-citrullinated protein antibodies (ACPAs), and other anti-modified protein anti-bodies are important risk factors for the development of rheumatoid arthritis (RA) and probably play an important role in its pathogenesis. In the phase before clinical arthritis becomes apparent, different autoantibody responses can evolve because of increases in their level, isotype switching, affinity maturation, epitope spreading, and a changing glycosylation profile. This evolution may be crucial for the pathogenic properties of the autoantibody responses, and interfering with this process in individuals at risk may become a route to prevent RA. Recent data suggest that interactions between RFs and ACPAs further amplify their inflammatory potential. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:42 / 52
页数:11
相关论文
共 50 条
  • [1] Abatacept in individuals with autoantibody-positive arthralgia at risk for rheumatoid arthritis
    van der Helm-van Mila, Annette H. M.
    LANCET, 2024, 403 (10429): : 785 - 787
  • [2] Evolution of Preclinical Autoimmunity in Individuals At Risk for Development of Rheumatoid Arthritis
    El-Gabalawy, Hani S.
    Robinson, David B.
    Smolik, Irene
    Hart, Donna M.
    Ferucci, Elizabeth D.
    Newkirk, Marianna M.
    Fritzler, Marvin J.
    Cramb, Catriona
    Sokolove, Jeremy
    Robinson, William H.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S722 - S722
  • [3] Elevated Oxylipin Profile in Autoantibody-Positive Individuals at-Risk of Developing Rheumatoid Arthritis
    Anaparti, Vidyanand
    Smolik, Irene
    Winter, Tanja
    Meng, Xiaobo
    Aukema, Harold
    El-Gabalawy, Hani
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] Symptoms in individuals at risk of rheumatoid arthritis
    Jutley, Gurpreet Singh
    Latif, Zahira P.
    Raza, Karim
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2017, 31 (01): : 59 - 70
  • [5] Abatacept in individuals at risk of rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2024, 6 (04): : e202 - e202
  • [6] Autoantibody profile in rheumatoid arthritis
    Feist, E.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 11 - 11
  • [7] Autoantibody profile in rheumatoid arthritis
    Feist, E.
    Egerer, K.
    Burmester, G-R.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 (03): : 212 - 218
  • [8] Predicting Rheumatoid Arthritis in At-risk Individuals
    van Boheemen, Laurette
    van Schaardenburg, Dirkjan
    CLINICAL THERAPEUTICS, 2019, 41 (07) : 1286 - 1298
  • [9] Prevotella copri in individuals at risk for rheumatoid arthritis
    Alpizar-Rodriguez, Deshire
    Lesker, Till Robin
    Gronow, Achim
    Gilbert, Benoit
    Raemy, Elena
    Lamacchia, Celine
    Gabay, Cem
    Finckh, Axel
    Strowig, Till
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (05) : 590 - 593
  • [10] Role of the lung in individuals at risk of rheumatoid arthritis
    Joshua, Vijay
    Chatzidionisyou, Katerini
    Catrina, Anca I.
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2017, 31 (01): : 31 - 41